An in-vitro assessment of the functional activity of monoclonal anti-D

Andrew G. Hadley, B Zupańska, K A Leader(NHS Blood and Transplant), Ewa Brojer(Instytut Hematologii i Transfuzjologi), Anthony H. Merry, Belinda M. Kumpel(NHS Blood and Transplant)

Clinical & Laboratory Haematology

March 1, 1989

10.1111/j.1365-2257.1989.tb00173.x

Cited by 31

Related Papers

A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy

|Blood|2013|226

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009

|Vox Sanguinis|2011|191

Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.

|PubMed|1994|107

Mechanism of anti-D-mediated immune suppression – a paradox awaiting resolution?

|Trends in Immunology|2001|103

Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti‐D immunoglobulin: more questions than answers

|Vox Sanguinis|2007|97